AR

Anand Ramcrisna Salgaocar

Director Director DIN 00044909
DIN 00044909 First appointment Jan 1980 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 1980
Shareholding value •••• Premium profile

About Anand Ramcrisna Salgaocar

Data last updated:

Anand Ramcrisna Salgaocar was a Director at Geno Pharmaceuticals Private Limited (1980–2019) and Director at Gaurav Products Private Limited (1984–2010). The companies operate in Pharma and Chemicals.

DIN 00044909
Primary Designation Director
Industry Pharma
First Appointment 31 Jan 1980

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Geno Pharmaceuticals Private Limited U24239GA1975PTC000250
Director31 Jan 19801975₹349 Cr (FY 2025)Active
Gaurav Products Private Limited U24232GA1981PTC000633
Director20 Jun 19841981Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Geno Pharmaceuticals Private Limited
Gaurav Products Private Limited
Premium access

Shareholding and investment profile for Anand Ramcrisna Salgaocar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anand Ramcrisna Salgaocar

Anand Ramcrisna Salgaocar was first appointed on 31 Jan 1980 as Director at Geno Pharmaceuticals Private Limited. The most recent appointment on record is 20 Jun 1984 at Gaurav Products Private Limited.

Anand Ramcrisna Salgaocar held 2 earlier board appointments: Geno Pharmaceuticals Private Limited (Director, 31 Jan 1980 to 12 Jul 2019); Gaurav Products Private Limited (Director, 20 Jun 1984 to 01 Feb 2010).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available